Ranitidina_predilu_Grif

Category

Ranitidina_predilu_Grif




Useful info

Ranitidina_predilu_Grif Brand names, Ranitidina_predilu_Grif Analogs

Ranitidina_predilu_Grif Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

    • Ranitidina_predilu_Grif Chemical_Formula

    C13H22N4O3S

    Ranitidina_predilu_Grif RX_link

    http://www.rxlist.com/cgi/generic2/ranitbc.htm

    Ranitidina_predilu_Grif fda sheet

    Ranitidina_predilu_Grif FDA

    Ranitidina_predilu_Grif msds (material safety sheet)

    Ranitidina_predilu_Grif MSDS

    Ranitidina_predilu_Grif Synthesis Reference

    B. J. Price et al., U.S. Pat. 4,128,658 (1978)

    Ranitidina_predilu_Grif Molecular Weight

    314.405 g/mol

    Ranitidina_predilu_Grif Melting Point

    69-70 oC

    Ranitidina_predilu_Grif H2O Solubility

    24.7 mg/mL

    Ranitidina_predilu_Grif State

    Solid

    Ranitidina_predilu_Grif LogP

    1.93

    Ranitidina_predilu_Grif Dosage Forms

    Capsule; Liquid; Solution; Tablet; Syrup

    Ranitidina_predilu_Grif Indication

    Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

    Ranitidina_predilu_Grif Pharmacology

    Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

    Ranitidina_predilu_Grif Absorption

    Approximately 50% bioavailability orally.

    Ranitidina_predilu_Grif Toxicity

    LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

    Ranitidina_predilu_Grif Patient Information

    PATIENT INFORMATION

    Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
    contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
    on the tongue.

    Ranitidina_predilu_Grif Organisms Affected

    Humans and other mammals